About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AVDL - Avadel Pharmaceutica...| Previous Close | $8.46 | Open | $8.50 |
| Volume | 517.4K | Market Cap | 492.99M |
| Yield | Last Dividend |
| Avadel Pharmaceuticals Announces Submiss... | 12/16/20 |
| DUBLIN, Ireland, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) today announced the submission of its New Drug Applicatio... | |
| Avadel Pharmaceuticals : Added to NASDAQ... | 12/15/20 |
| DUBLIN, Ireland, Dec. 15, 2020 -- Avadel Pharmaceuticals plc , a company focused on developing FT218, an investigational, once-nightly formulation of ... | |
| Avadel Pharmaceuticals (NASDAQ:AVDL) Low... | 10/25/20 |
| Avadel Pharmaceuticals (NASDAQ:AVDL) was downgraded by research analysts at BidaskClub from a ???sell??? rating to a ???strong sell??? rating in a res... | |
| Avadel Pharmaceuticals (NASDAQ:AVDL) Sto... | 10/24/20 |
| Avadel Pharmaceuticals (NASDAQ:AVDL) was downgraded by analysts at BidaskClub from a ???sell??? rating to a ???strong sell??? rating in a research rep... | |
| Avadel Pharmaceuticals (NASDAQ:AVDL) Dow... | 10/24/20 |
| BidaskClub cut shares of Avadel Pharmaceuticals (NASDAQ:AVDL) from a sell rating to a strong sell rating in a report issued on Friday morning, BidAskC... | |
| Avadel Pharmaceuticals plc to Post FY202... | 10/23/20 |
| Avadel Pharmaceuticals plc (NASDAQ:AVDL) ??? SVB Leerink decreased their FY2022 earnings estimates for Avadel Pharmaceuticals in a report issued on Tu... | |
| FY2022 EPS Estimates for Avadel Pharmace... | 10/22/20 |
| Avadel Pharmaceuticals plc (NASDAQ:AVDL) ??? Equities research analysts at SVB Leerink lowered their FY2022 earnings per share estimates for shares of... | |
| North America Psychedelic Drugs Market 2... | 10/07/20 |
| To prepare this Psychedelic Drugs Market research report, an array of objectives of market research has been considered. While formulating this market... | |
| Avadel Pharmaceuticals to Report Second ... | 07/27/20 |
| DUBLIN, Ireland, July 27, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that it will host a conference call and l... | |
| Avadel Pharmaceuticals Announces First P... | 07/13/20 |
| Clinical study to enroll 250 patients from sites that participated in the REST-ON studyStudy to examine the long-term safety and maintenance of effica... | |
| Avadel sells hospital sterile injectable... | 07/01/20 |
| Avadel Pharmaceuticals (AVDL -1.4%) sold its portfolio of sterile injectable drugs used in the hospital setting, including three commercial products, ... | |
| How Avadel (AVDL) Stock Stands Out in a ... | 06/01/20 |
| Avadel (AVDL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | |
| Avadel (AVDL) Beats on Earnings & Revenu... | 05/11/20 |
| Avadel's (AVDL) first quarter 2020 earnings and revenues surpass expectations. | |
| Avadel Pharmaceuticals to Report First Q... | 05/04/20 |
| DUBLIN, Ireland, May 04, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational... | |
| Is a Beat in Store for Avadel (AVDL) Thi... | 04/28/20 |
| On Avadel's (AVDL) Q1 earnings call, investor focus will be on the company's lead candidate, FT218, currently being evaluated to treat excessive dayti... | |
| The Daily Biotech Pulse: Pfizer Earnings... | 04/28/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) As... | |
| Stock Alert: Avadel Pharma Up 37% In Pre... | 04/27/20 |
| Shares of Avadel Pharmaceuticals plc (AVDL) are soaring over 37% in pre-market today, after the company announced positive topline data from its pivot... | |
| Is Avadel Pharmaceuticals (AVDL) Stock a... | 04/15/20 |
| Avadel Pharmaceuticals (AVDL) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | |
| Avadel Pharma completes late-stage FT218... | 03/25/20 |
| Avadel Pharmaceuticals (NASDAQ:AVDL) has completed the REST-ON Phase 3 clinical trial for FT218. The study enrolled a total of 212 patients. Topline d... | |
| The Daily Biotech Pulse: Moderna Ships C... | 02/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ... | |
| The Daily Biotech Pulse: European Nod Fo... | 12/12/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) ... | |
| The Daily Biotech Pulse: Correvio Faces ... | 12/11/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) ... | |
| The Daily Biotech Pulse: ASH Meeting Wra... | 12/10/19 |
| The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acce... | |
| The Daily Biotech Pulse: Tonix Says No S... | 11/27/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26) ... | |
| The Daily Biotech Pulse: ChemoCentryx Tr... | 11/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.... | |
| The Daily Biotech Pulse: Sandoz Recalls ... | 09/24/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| Why Shares of Micro-Cap Biotech Avadel A... | 09/23/19 |
| Micro-cap biotech Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) was adding about one-half to its market capitalization Monday on roughly 27 times the ave... | |
| Avadel Pharmaceuticals (AVDL) Interim CE... | 05/08/19 |
| Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2019 Earnings Conference Call May 8, 2019, 08:30 AM ET Company Participants Greg Divis - Interim CEO Mike ... | |
| Avadel Pharmaceuticals beats by $0.14, b... | 05/08/19 |
| No summary available. | |
| Avadel Pharmaceuticals Reports First Qua... | 05/08/19 |
| REST-ON 63% enrolled; 98 patients remain to be enrolled Jordon Dubow, M.D., appointed as Chief Medical Officer Noctiva???-related assets sold; all ope... | |
| Date | 2021-03-09 (BMO) | Est. (EPS/Rev.) | ($0.27)/ 0 |
| Actual (EPS/Rev.) | / | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Short Plays | Eric Cunningham | 40.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
